Nath Bio-Genes (India) Limited Capital Reinvestment Ratio
Nath Bio-Genes (India) Limited capital reinvestment ratio. Nath Bio-Genes (India) Limited (NATHBIOGEN) has a Capital Reinvestment Ratio of 0.45x as of March 2025, meaning it reinvests 0% of its operating cash flow (Rs175.81 Million) in capital expenditures (Rs79.20 Million). Check NATHBIOGEN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Nath Bio-Genes (India) Limited (2013–2025)
Capital reinvestment ratio of Nath Bio-Genes (India) Limited from 2013 to 2025. This chart tracks Nath Bio-Genes (India) Limited's Capital Reinvestment Ratio across 10 annual periods. Also explore net asset growth rate of Nath Bio-Genes (India) Limited to track the company's year-over-year net asset growth rate.
Nath Bio-Genes (India) Limited Capital Reinvestment Ratio by Year (2013–2025)
Nath Bio-Genes (India) Limited capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see Nath Bio-Genes (India) Limited cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | Rs175.81 Million | Rs79.20 Million | ▲ +230.0% |
| 2024 | 0.14x | Rs614.80 Million | Rs83.93 Million | ▲ +105.5% |
| 2023 | 0.07x | Rs383.67 Million | Rs25.49 Million | ▼ -94.6% |
| 2022 | 1.23x | Rs170.46 Million | Rs210.17 Million | ▼ -88.2% |
| 2021 | 10.42x | Rs11.13 Million | Rs115.98 Million | ▲ +509.4% |
| 2020 | 1.71x | Rs94.74 Million | Rs162.03 Million | ▲ +38.6% |
| 2017 | 1.23x | Rs33.43 Million | Rs41.26 Million | ▲ +1080.6% |
| 2015 | 0.10x | Rs67.55 Million | Rs7.06 Million | ▼ -45.7% |
| 2014 | 0.19x | Rs150.28 Million | Rs28.95 Million | ▼ -87.2% |
| 2013 | 1.50x | Rs142.11 Million | Rs213.54 Million | — |